Peritoneal Surface Oncology Group International
@PSOGI_EC
Followers
2K
Following
4K
Media
868
Statuses
6K
Official twitter account of the Peritoneal Surface Oncology Group International (PSOGI) Views expressed are those of the SoMe head of PSOGI @writeslkpushkin
Around the world
Joined August 2021
PSOGI is a collaboration of world–renowned experts on the treatment of peritoneal cancer, founded & chaired by Paul Sugarbaker PSOGI aims to improve outcomes of patients with PC by educating patients, training physicians, organizing meetings & performing basic & clinical research
12
8
45
Congress materials from @PSOGI_EC Barcelona are now available: Recordings Poster presentations Registered participants will receive their access credentials separately. Non-attendees may purchase full access for €50+VAT(21%). Access & registration, here: https://t.co/BhjfNlDa3A
0
1
2
Join us on zoom or watch the live stream on YouTube
🔊 🚫 Block your dates for 🚫 🔊 CASE OF THE MONTH #48 on 📹 zoom CASE #48: Unresectable #advanced #tuboovarian carcinoma after neoadjuvant chemotherapy: personalized therapeutic strategies #ovariancancer #advancedovariancancer #CRS #HIPEC #PIPAC 👨🏫 Moderated by Aditi Bhatt
0
0
1
🔊 🚫 Block your dates for 🚫 🔊 CASE OF THE MONTH #48 on 📹 zoom CASE #48: Unresectable #advanced #tuboovarian carcinoma after neoadjuvant chemotherapy: personalized therapeutic strategies #ovariancancer #advancedovariancancer #CRS #HIPEC #PIPAC 👨🏫 Moderated by Aditi Bhatt
0
13
11
Impact of prophylactic bilateral salpingo-oophorectomy in patients with colorectal cancer with peritoneal metastasis during cytoreductive surgery: dual-center cohort analysis ➡️ https://t.co/7OhxPkC4mu For colorectal cancer patients with peritoneal metastasis and bilateral
1
12
29
#Editorial Primary or interval debulking? The question persists but the answer lies in patient selection by Jessica Floyd and Pedro Ramirez 🔍 https://t.co/Hd3NBz2Plj
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert
0
6
23
very informative article, thank you for sharing! While we are on the topic of 2nd opinions, please check-out the 2nd Opinion guide on @colontown university! https://t.co/4eKtMAxd9b
#CRCSM
What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Review | JCO Oncology Practice
0
3
5
#LeadArticle #SUROVAstudy: global real-world treatment strategies and mortality risk prediction in advanced #ovariancancer New global real-world data (n=3,286) finds no difference in 5-year survival between primary surgery & neoadjuvant chemo for advanced ovarian cancer. 💡
2
12
23
[1/3] 📅Mardi 2 décembre, participez à la journée mondiale de la générosité ! Les maladies rares du péritoine restent encore trop méconnues. Depuis 2007, @AssocAmarape se bat aux côtés des patients, proches pour informer et soutenir la recherche médicale. #GivingTuesdayFR
1
2
2
Is selective peritonectomy as good as total peritonectomy❓ Join us for a hot 🔥 debate on this topic at #ESGO2026! Arguing pro: Aditi Bhatt 🇮🇳 Arguing against: Nadeem Abu-Rustum 🇺🇸 Moderator: Pernille Tine Jensen 🇩🇰 They will cover the oncological rationale and potential
0
6
13
La Dra Silvia Guerrero y el Dr @drmaikelp presentan e invitan a la Comunidad Oncológica al Septimo Encuetro LatinoAmericano para el Manejo de la Enfermedad Peritoneal . #PSOGI2025 #Barcelona
#TodosVsElCáncer
0
2
4
The big debate in #ovariancancer continues🔥 🔥 🎙️ Tune into our new #IJGCconversations episode with Dr. Luis Chiva @lchiv4 discussing the #SUROVAstudy 🎧 https://t.co/0aF2cOsiQ3
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official
3
12
22
🔊 🚫 Block your dates for 🚫 🔊 CASE OF THE MONTH #48 on 📹 zoom CASE #48: Unresectable #advanced #tuboovarian carcinoma after neoadjuvant chemotherapy: personalized therapeutic strategies #ovariancancer #advancedovariancancer #CRS #HIPEC #PIPAC 👨🏫 Moderated by Aditi Bhatt
0
13
11
Pelvic Sidewall Recurrence of Rectal Cancer with External Iliac Vessel Involvement: A Stent-Graft–Assisted Multidisciplinary Surgical Approach The patient had a history of mid-rectal adenocarcinoma and underwent neoadjuvant chemoradiotherapy followed by curative surgery two
0
1
4
📅Encore quelques jours pour vous inscrire au prochain #RDVAMARAPE : "Présentation du manifeste patients" dévoilé au #PSOGI2025 par Bernard, Didier, Jeanne qui ont représenté notre association et en présence de Sandra de l'asociacion peritoneum et Pr #DianeGoéré @APHP @PSOGI_EC
1
2
2
Check out the Peritoneal Surface Oncology Group International (PSOGI) YouTube 🎥 Channel https://t.co/LtTqjWUWkQ 🎦 Subscribe 🆓 🈚 All the previous 🎧 podcasts 🎧 are now available on this channel 1️⃣ Netherlands Cancer Registry - what can we learn from it?
0
9
12
Congratulations to the newly elected ESGO Officers! 🎉 Ane Gerda Eriksson 🇳🇴 was voted President-Elect & Viola Heinzelmann-Schwarz 🇨🇭was voted Vice President at an online ESGO Council meeting today! They will take office following #ESGO2026 in Copenhagen in February along with
3
4
23
CASE OF THE MONTH #47
https://t.co/st5DdauOG0 via @YouTube Subscribe to the Peritoneal Surface Oncology Group International (PSOGI) YouTube channel https://t.co/LtTqjWUWkQ
@DrSGlezMoreno @indepso @PompiliuPiso @FarazKh65499316 @DrFloresAyala
youtube.com
The Peritoneal Surface Oncology Group International (PSOGI) is a non-profit organization that promote researchs, education, and innovations in patient care regarding peritoneal malignancies. The...
0
3
5
Stromal Tumor infiltrating lymphocytes (sTILs) as a prognostic biomark...
0
1
2